Real-World Bleeding Risks in Non-Valvular Atrial Fibrillation Patients with Heart Failure: Contemporary HER Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban, and Warfarin.

Authors: Iris Lin, Ruslan Horblyuk, Jack Mardekian, Sang Hee Park, Shital Kamble, Melissa Hamilton, Younos Abdulsattar, William Petkun, Joseph Menzin, and Gregory Y Lip

Published: Circulation, 2018.

Click here for the article: